Nihal Engin Vrana,
Fundamental Research Manager,
PROTiP
Nihal Engin Vrana is Vice President (Scientific Affairs) of Protip Medical and affiliated with INSERM Unit 1121 in Strasbourg, France. Protip Medical develops breakthrough solutions in the field of Otorhinolaryngology which resulted in the implantation of world’s first functional artificial larynx in humans in 2012 (www.protipmedical.com). He obtained his PhD in 2009 at Dublin City University as an EU FP 7 Marie Curie ESR fellow. His research unit’s activities in the field of tissue engineering include development of immunoassisted engineered tissues and hybrids of mechanical implants and tissue engineered structures. His major research interests are titanium implants, tissue engineering, cell encapsulation, immunomodulation, real-time biosensor based monitoring of implants and cell biomaterials interactions. Currently, He is the scientific coordinator of FP7 IMMODGEL project which strives to develop solutions to adverse immune reactions against biomaterial based implantable system including tissue engineered systems (www.immodgel.org). Since its formation in 2012, his unit has been involved in National and International multi-partner project with a total budget of nearly 15 Million Euros either as a participant or coordinator. He has published 42 articles in peer-reviewed academic journals (over 800 citations, h index: 17) 5 book chapters and holds 2 European patents (and 2 more applications). In addition to over 90 presentations in international conferences, he has given 22 invited lectures in National and International events. Aside from TERMIS-EU, he is a member of e-MRS, Marie Curie Fellows Association, Turkish Biomaterials and Tissue Engineering Association and Alsace Biovalley. He regularly acts as a reviewer for journals such as Biomacromolecules, Acta Biomaterialia, Biofabrication, Molecular Pharmaceutics, Journal of Tissue Engineering and Regenerative Medicine, Biomedical Materials and also evaluates projects at European Union level and several National European agencies. He recently edited a book for Taylor and Francis on Cell Material Interactions (2015). His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012), IFOS Outstanding paper award (2013). His outreach activities include scientific consultancy for Bio-Punk: An anthology of bioengineered futures.’ short story compilation (supported by Wellcome Trust) and an invited article in French popular biotechnology journal “Biofutur” about the clinical application of artificial larynx. Being in the interface between industry and academic research he has the necessary networks and the skill set to contribute to TERMIS-EU Strategic Alliance Committee both by actively collaborating with other societies such as ISCT or with other stakeholders such as National notified bodies, biomaterial and cell manipulation related companies and industrial entities and clinicians.
|
|
|